Biotechnology
The Biotechnology industry has a total of 584 stocks, with a combined market cap of $1.22 trillion and total revenue of $109.16 billion.
Market Cap
1.22T
Revenue
109.16B
Profits
-41.15B
PE Ratio
n/a
Profit Margin
-37.70%
Dividend Yield
0.04%
584 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 122.56B | 0.50% | 89,596 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 68.56B | 0.26% | 56,162 | 14.92B |
| 3 | ARGX | argenx SE | 53.79B | 3.08% | 45,370 | 4.74B |
| 4 | RVMD | Revolution Medicines, Inc. | 38.90B | 1.42% | 145,239 | - |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 36.60B | 0.54% | 55,315 | 4.29B |
| 6 | ONC | BeOne Medicines AG | 35.54B | 2.93% | 139,961 | 5.74B |
| 7 | RPRX | Royalty Pharma plc | 33.13B | 0.43% | 230,564 | 2.44B |
| 8 | ROIV | Roivant Sciences Ltd. | 25.03B | 2.20% | 278,306 | 8.26M |
| 9 | MRNA | Moderna, Inc. | 23.90B | 1.24% | 693,253 | 2.23B |
| 10 | BNTX | BioNTech SE | 23.63B | 1.40% | 110,538 | 3.23B |
| 11 | INCY | Incyte Corporation | 23.54B | 1.86% | 102,345 | 5.36B |
| 12 | INSM | Insmed Incorporated | 23.19B | -0.03% | 214,013 | 819.56M |
| 13 | GMAB | Genmab A/S | 17.31B | 2.01% | 174,575 | 3.90B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 15.91B | 0.50% | 119,180 | 579.96M |
| 15 | ASND | Ascendis Pharma A/S | 15.76B | 0.80% | 72,203 | 998.25M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.44B | 0.98% | 55,523 | 4.44B |
| 17 | EXEL | Exelixis, Inc. | 14.10B | 0.99% | 115,063 | 2.38B |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.56B | 1.67% | 17,213 | 1.13B |
| 19 | ABVX | ABIVAX Société Anonyme | 11.61B | 1.52% | 83,931 | 5.67M |
| 20 | AXSM | Axsome Therapeutics, Inc. | 11.53B | 1.09% | 142,114 | 708.24M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 11.50B | 0.64% | 78,460 | 3.24B |
| 22 | TECH | Bio-Techne Corporation | 11.17B | 0.01% | 963,910 | 1.21B |
| 23 | SMMT | Summit Therapeutics Inc. | 10.92B | 4.22% | 145,878 | - |
| 24 | CYTK | Cytokinetics, Incorporated | 10.81B | 0.62% | 81,282 | 105.82M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.34B | 2.47% | 134,556 | 622.01M |
| 26 | CORT | Corcept Therapeutics Incorporated | 10.23B | 4.06% | 76,649 | 769.10M |
| 27 | APGE | Apogee Therapeutics, Inc. | 10.06B | 0.07% | 79,387 | - |
| 28 | KRYS | Krystal Biotech, Inc. | 9.89B | -1.08% | 75,831 | 417.30M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 9.27B | 1.35% | 63,361 | 1.51B |
| 30 | KYMR | Kymera Therapeutics, Inc. | 9.19B | 0.62% | 42,353 | 51.48M |
| 31 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.85B | 0.10% | 1,084,722 | 18.07M |
| 32 | IONS | Ionis Pharmaceuticals, Inc. | 8.78B | 0.28% | 146,868 | 1.06B |
| 33 | SYRE | Spyre Therapeutics, Inc. | 8.77B | 2.41% | 90,140 | - |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 8.66B | 0.35% | 43,545 | 74.06M |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 8.59B | 1.24% | 15,018 | 7.46M |
| 36 | IBRX | ImmunityBio, Inc. | 8.21B | 4.60% | 1,279,184 | 140.98M |
| 37 | IMVT | Immunovant, Inc. | 8.17B | -0.29% | 58,077 | - |
| 38 | PCVX | Vaxcyte, Inc. | 8.13B | 1.43% | 106,239 | - |
| 39 | TGTX | TG Therapeutics, Inc. | 7.75B | 1.32% | 133,095 | 700.35M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.28B | 1.50% | 42,921 | 217.17M |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 7.13B | 0.23% | 18,209 | 569.61M |
| 42 | ERAS | Erasca, Inc. | 6.68B | 2.18% | 264,353 | - |
| 43 | PTCT | PTC Therapeutics, Inc. | 6.65B | 2.76% | 188,563 | 827.11M |
| 44 | COGT | Cogent Biosciences, Inc. | 6.64B | 1.41% | 94,640 | - |
| 45 | XENE | Xenon Pharmaceuticals Inc. | 6.40B | 0.30% | 63,175 | 7.50M |
| 46 | CGON | CG Oncology, Inc. | 6.25B | 0.93% | 39,710 | 5.07M |
| 47 | BLTE | Belite Bio, Inc | 6.06B | 0.76% | 10,971 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 6.06B | -0.24% | 45,196 | - |
| 49 | LGND | Ligand Pharmaceuticals Incorporated | 5.88B | 0.89% | 19,183 | 274.48M |
| 50 | DFTX | Definium Therapeutics, Inc. | 5.80B | 2.09% | 231,757 | - |
| 51 | ORKA | Oruka Therapeutics, Inc. | 5.67B | 2.53% | 82,189 | - |
| 52 | DNTH | Dianthus Therapeutics, Inc. | 5.65B | 2.31% | 52,010 | 1.34M |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.12B | -0.67% | 60,702 | 536.20M |
| 54 | CRSP | CRISPR Therapeutics AG | 4.74B | 2.32% | 188,435 | 4.10M |
| 55 | MANE | Veradermics, Incorporated | 4.57B | 3.09% | 40,431 | - |
| 56 | LEGN | Legend Biotech Corporation | 4.53B | 0.86% | 111,986 | 1.14B |
| 57 | CAI | Caris Life Sciences, Inc. | 4.51B | 2.51% | 318,948 | 907.29M |
| 58 | VKTX | Viking Therapeutics, Inc. | 4.36B | 3.11% | 180,621 | - |
| 59 | CELC | Celcuity Inc. | 4.34B | 1.09% | 98,444 | - |
| 60 | ACAD | ACADIA Pharmaceuticals Inc. | 4.31B | 0.38% | 260,684 | 1.10B |
| 61 | RLAY | Relay Therapeutics, Inc. | 4.27B | 2.11% | 144,492 | 10.68M |
| 62 | EWTX | Edgewise Therapeutics, Inc. | 4.25B | 1.78% | 20,920 | - |
| 63 | TNGX | Tango Therapeutics, Inc. | 4.08B | 2.36% | 67,942 | 56.99M |
| 64 | DYN | Dyne Therapeutics, Inc. | 3.93B | 1.32% | 181,209 | - |
| 65 | ELVN | Enliven Therapeutics, Inc. | 3.68B | 2.03% | 77,247 | - |
| 66 | DNLI | Denali Therapeutics Inc. | 3.68B | 1.27% | 184,255 | - |
| 67 | ALMS | Alumis Inc. | 3.65B | 2.27% | 39,057 | 8.40M |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.64B | 2.88% | 58,615 | 236.00M |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.64B | 2.66% | 31,837 | 803.79M |
| 70 | PBLS | Parabilis Medicines, Inc. | 3.59B | 3.35% | 25,086 | - |
| 71 | NAMS | NewAmsterdam Pharma Company N.V. | 3.55B | 2.46% | 108,588 | 22.57M |
| 72 | ARQT | Arcutis Biotherapeutics, Inc. | 3.46B | 0.62% | 33,880 | 415.62M |
| 73 | GPCR | Structure Therapeutics Inc. | 3.39B | 1.66% | 30,171 | - |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 3.39B | 0.65% | 31,331 | 225.27M |
| 75 | MBX | MBX Biosciences, Inc. | 2.85B | -0.47% | 84,752 | - |
| 76 | IRON | Disc Medicine, Inc. | 2.83B | -0.22% | 16,156 | - |
| 77 | RARE | Ultragenyx Pharmaceutical Inc. | 2.81B | 0.39% | 93,070 | 670.00M |
| 78 | QURE | uniQure N.V. | 2.77B | 1.60% | 95,493 | 18.09M |
| 79 | CLDX | Celldex Therapeutics, Inc. | 2.74B | -1.50% | 114,427 | 865.00K |
| 80 | BEAM | Beam Therapeutics Inc. | 2.68B | 2.09% | 220,607 | 164.01M |
| 81 | ATAI | AtaiBeckley Inc. | 2.66B | 0.07% | 2,229,162 | 3.49M |
| 82 | VERA | Vera Therapeutics, Inc. | 2.65B | -0.16% | 119,386 | - |
| 83 | KOD | Kodiak Sciences Inc. | 2.63B | 3.03% | 30,404 | - |
| 84 | TRVI | Trevi Therapeutics, Inc. | 2.53B | 6.08% | 196,901 | - |
| 85 | IMNM | Immunome, Inc. | 2.52B | 0.61% | 52,128 | 4.02M |
| 86 | TARS | Tarsus Pharmaceuticals, Inc. | 2.46B | 1.69% | 38,032 | 535.08M |
| 87 | SLS | SELLAS Life Sciences Group, Inc. | 2.45B | -0.32% | 831,596 | - |
| 88 | NRIX | Nurix Therapeutics, Inc. | 2.39B | 1.23% | 47,548 | 36.77M |
| 89 | MLYS | Mineralys Therapeutics, Inc. | 2.38B | 1.20% | 33,640 | - |
| 90 | IOVA | Iovance Biotherapeutics, Inc. | 2.37B | 5.78% | 2,926,165 | 285.61M |
| 91 | KLRA | Kailera Therapeutics, Inc. | 2.36B | 1.73% | 29,228 | - |
| 92 | PHVS | Pharvaris N.V. | 2.35B | 0.12% | 15,900 | - |
| 93 | ZLAB | Zai Lab Limited | 2.33B | 0.88% | 66,592 | 453.28M |
| 94 | VCEL | Vericel Corporation | 2.32B | -0.88% | 46,300 | 292.09M |
| 95 | AGIO | Agios Pharmaceuticals, Inc. | 2.32B | -2.65% | 718,577 | 66.05M |
| 96 | BHVN | Biohaven Ltd. | 2.30B | 2.83% | 118,684 | - |
| 97 | COAG | Hemab Therapeutics Holdings, Inc. | 2.27B | -1.50% | 27,603 | - |
| 98 | NUVB | Nuvation Bio Inc. | 2.23B | 2.48% | 627,928 | 143.05M |
| 99 | NKTR | Nektar Therapeutics | 2.20B | 0.25% | 95,439 | 55.63M |
| 100 | SION | Sionna Therapeutics, Inc. | 2.13B | 3.37% | 92,134 | - |
| 101 | MESO | Mesoblast Limited | 2.11B | -1.98% | 42,340 | 65.38M |
| 102 | VRDN | Viridian Therapeutics, Inc. | 2.06B | 0.70% | 87,264 | 70.92M |
| 103 | URGN | UroGen Pharma Ltd. | 2.06B | 2.89% | 157,552 | 140.49M |
| 104 | DMRA | Damora Therapeutics, Inc. | 2.05B | 0.94% | 35,899 | - |
| 105 | GLUE | Monte Rosa Therapeutics, Inc. | 2.03B | 2.43% | 61,846 | 42.95M |
| 106 | ADMA | ADMA Biologics, Inc. | 2.01B | -0.69% | 210,043 | 509.86M |
| 107 | AUPH | Aurinia Pharmaceuticals Inc. | 1.99B | 1.31% | 82,278 | 298.30M |
| 108 | SNDX | Syndax Pharmaceuticals, Inc. | 1.98B | 0.40% | 73,455 | 217.17M |
| 109 | OCUL | Ocular Therapeutix, Inc. | 1.98B | 3.79% | 159,508 | 52.04M |
| 110 | ZBIO | Zenas BioPharma, Inc. | 1.98B | 2.02% | 38,381 | 10.00M |
| 111 | PVLA | Palvella Therapeutics, Inc. | 1.96B | 10.25% | 76,476 | - |
| 112 | RAPP | Rapport Therapeutics, Inc. | 1.95B | 1.63% | 11,923 | 20.00M |
| 113 | LKFT | Lakefront Biotherapeutics NV | 1.93B | 0.48% | 18,393 | 1.20B |
| 114 | HRMY | Harmony Biosciences Holdings, Inc. | 1.93B | -0.48% | 96,280 | 899.11M |
| 115 | GHRS | GH Research PLC | 1.93B | 1.96% | 19,958 | - |
| 116 | KARD | Kardigan, Inc. | 1.89B | -1.17% | 34,938 | - |
| 117 | PGEN | Precigen, Inc. | 1.87B | 3.55% | 409,958 | 31.60M |
| 118 | TYRA | Tyra Biosciences, Inc. | 1.87B | 1.30% | 15,110 | - |
| 119 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.83B | 1.22% | 227,168 | 204.73M |
| 120 | TSHA | Taysha Gene Therapies, Inc. | 1.81B | 1.43% | 131,495 | 7.47M |
| 121 | NBTX | Nanobiotix S.A. | 1.81B | 5.09% | 10,001 | 38.27M |
| 122 | BCAX | Bicara Therapeutics Inc. | 1.80B | 0.90% | 13,252 | - |
| 123 | GENB | Generate Biomedicines, Inc. | 1.79B | 3.09% | 61,184 | 30.30M |
| 124 | SRPT | Sarepta Therapeutics, Inc. | 1.79B | 0.59% | 270,468 | 2.18B |
| 125 | ABCL | AbCellera Biologics Inc. | 1.77B | -0.34% | 1,543,424 | 79.21M |
| 126 | IMCR | Immunocore Holdings plc | 1.73B | -0.15% | 10,303 | 412.81M |
| 127 | AAPG | Ascentage Pharma Group International | 1.72B | - | 30 | 82.08M |
| 128 | STOK | Stoke Therapeutics, Inc. | 1.72B | -0.43% | 41,219 | 32.08M |
| 129 | ZYME | Zymeworks Inc. | 1.71B | 0.51% | 63,832 | 81.26M |
| 130 | FTRE | Fortrea Holdings Inc. | 1.71B | 1.80% | 107,972 | 2.71B |
| 131 | MPLT | MapLight Therapeutics, Inc. | 1.70B | 4.20% | 58,133 | - |
| 132 | INVA | Innoviva, Inc. | 1.59B | 1.50% | 63,362 | 420.69M |
| 133 | MLTX | MoonLake Immunotherapeutics | 1.59B | 1.21% | 68,124 | - |
| 134 | MAZE | Maze Therapeutics, Inc. | 1.59B | 1.13% | 13,195 | 20.00M |
| 135 | RXRX | Recursion Pharmaceuticals, Inc. | 1.59B | 3.46% | 2,071,107 | 66.41M |
| 136 | VIR | Vir Biotechnology, Inc. | 1.59B | 1.84% | 106,282 | 65.50M |
| 137 | NTLA | Intellia Therapeutics, Inc. | 1.57B | 3.21% | 540,652 | 66.09M |
| 138 | ANAB | AnaptysBio, Inc. | 1.53B | 2.68% | 99,767 | 232.39M |
| 139 | SEPN | Septerna, Inc. | 1.48B | 1.80% | 16,069 | 72.26M |
| 140 | XNCR | Xencor, Inc. | 1.47B | 5.10% | 102,244 | 97.36M |
| 141 | TRAX | First Tracks Biotherapeutics, Inc. | 1.45B | 12.58% | 123,043 | - |
| 142 | SVRA | Savara Inc. | 1.40B | 0.73% | 93,276 | - |
| 143 | AKTS | Aktis Oncology, Inc. | 1.36B | 2.67% | 10,297 | 8.28M |
| 144 | ABSI | Absci Corporation | 1.35B | -2.57% | 460,673 | 1.84M |
| 145 | NVAX | Novavax, Inc. | 1.32B | 1.52% | 273,262 | 596.34M |
| 146 | AVBP | ArriVent BioPharma, Inc. | 1.29B | -1.84% | 60,810 | - |
| 147 | IMTX | Immatics N.V. | 1.28B | 1.30% | 19,770 | 43.00M |
| 148 | INBX | Inhibrx Biosciences, Inc. | 1.27B | 3.32% | 26,687 | 1.30M |
| 149 | AVLN | Avalyn Pharma Inc. | 1.26B | -0.51% | 5,454 | - |
| 150 | FBRX | Forte Biosciences, Inc. | 1.25B | 7.92% | 201,436 | - |
| 151 | ARDX | Ardelyx, Inc. | 1.25B | -0.79% | 360,848 | 427.68M |
| 152 | MNKD | MannKind Corporation | 1.24B | 1.01% | 248,227 | 360.78M |
| 153 | CRVS | Corvus Pharmaceuticals, Inc. | 1.21B | 2.41% | 34,782 | - |
| 154 | DRTS | Alpha Tau Medical Ltd. | 1.20B | -0.97% | 302,368 | - |
| 155 | JBIO | Jade Biosciences, Inc. | 1.19B | 2.29% | 58,897 | - |
| 156 | MGTX | MeiraGTx Holdings plc | 1.15B | 1.47% | 30,318 | 79.76M |
| 157 | ORIC | ORIC Pharmaceuticals, Inc. | 1.12B | 3.93% | 124,837 | - |
| 158 | WVE | Wave Life Sciences Ltd. | 1.12B | 1.40% | 116,498 | 71.80M |
| 159 | SPTX | Seaport Therapeutics, Inc. | 1.11B | 0.68% | 2,611 | - |
| 160 | CAPR | Capricor Therapeutics, Inc. | 1.10B | -2.15% | 268,081 | 11.13M |
| 161 | CGEM | Cullinan Therapeutics, Inc. | 1.09B | 1.54% | 54,520 | - |
| 162 | EYPT | EyePoint, Inc. | 1.06B | 0.32% | 80,397 | 7.61M |
| 163 | IVA | Inventiva S.A. | 1.04B | 0.79% | 177,640 | 7.94M |
| 164 | ANRO | Alto Neuroscience, Inc. | 1.04B | 3.30% | 49,468 | - |
| 165 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -0.86% | 297,142 | 69.64M |
| 166 | OLMA | Olema Pharmaceuticals, Inc. | 1.01B | 1.54% | 65,249 | - |
| 167 | VOR | Vor Biopharma Inc. | 986.18M | 4.30% | 169,831 | - |
| 168 | JANX | Janux Therapeutics, Inc. | 978.19M | -0.06% | 60,739 | 13.73M |
| 169 | AVTX | Avalo Therapeutics, Inc. | 977.65M | 1.48% | 125,679 | 59.00K |
| 170 | SANA | Sana Biotechnology, Inc. | 959.68M | 1.91% | 206,792 | - |
| 171 | KURA | Kura Oncology, Inc. | 937.46M | -1.12% | 112,850 | 71.64M |
| 172 | GERN | Geron Corporation | 920.58M | -0.35% | 283,844 | 196.12M |
| 173 | PHAR | Pharming Group N.V. | 911.72M | 0.57% | 668 | 369.49M |
| 174 | LBRX | LB Pharmaceuticals Inc | 906.90M | 2.35% | 12,011 | - |
| 175 | REPL | Replimune Group, Inc. | 904.09M | 2.47% | 399,665 | - |
| 176 | ANNX | Annexon, Inc. | 897.04M | -1.71% | 758,291 | - |
| 177 | TBPH | Theravance Biopharma, Inc. | 875.12M | 0.45% | 115,762 | 109.78M |
| 178 | ABUS | Arbutus Biopharma Corporation | 875.09M | 0.45% | 185,378 | 191.45M |
| 179 | ODTX | Odyssey Therapeutics, Inc. | 853.43M | 1.39% | 14,635 | 1.06M |
| 180 | PHAT | Phathom Pharmaceuticals, Inc. | 843.55M | -0.28% | 42,543 | 204.89M |
| 181 | DBVT | DBV Technologies S.A. | 839.30M | -2.40% | 217,517 | 5.04M |
| 182 | SLDB | Solid Biosciences Inc. | 825.01M | -0.83% | 85,408 | - |
| 183 | TENX | Tenax Therapeutics, Inc. | 815.42M | 1.79% | 97,289 | - |
| 184 | ACRS | Aclaris Therapeutics, Inc. | 780.72M | 0.36% | 76,242 | 8.37M |
| 185 | AURA | Aura Biosciences, Inc. | 764.38M | 1.61% | 44,000 | - |
| 186 | CTMX | CytomX Therapeutics, Inc. | 758.69M | -0.99% | 195,872 | 35.54M |
| 187 | DSGN | Design Therapeutics, Inc. | 745.74M | 0.59% | 15,399 | - |
| 188 | CLYM | Climb Bio, Inc. | 732.93M | 4.75% | 147,969 | - |
| 189 | FTH | Faeth Therapeutics, Inc. | 729.54M | 0.39% | 88,396 | - |
| 190 | RIGL | Rigel Pharmaceuticals, Inc. | 728.61M | -0.73% | 16,704 | 299.77M |
| 191 | DRUG | Bright Minds Biosciences Inc. | 728.33M | 2.14% | 24,580 | - |
| 192 | CADL | Candel Therapeutics, Inc. | 727.57M | 3.76% | 85,433 | - |
| 193 | NGNE | Neurogene Inc. | 726.14M | -2.41% | 16,964 | 925.00K |
| 194 | ZVRA | Zevra Therapeutics, Inc. | 725.93M | 2.08% | 152,586 | 122.29M |
| 195 | MNPR | Monopar Therapeutics Inc. | 721.39M | 1.69% | 13,642 | - |
| 196 | OCS | Oculis Holding AG | 715.90M | 1.07% | 20,207 | 1.40M |
| 197 | OMER | Omeros Corporation | 698.42M | 0.21% | 71,809 | 9.89M |
| 198 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 680.91M | 0.95% | 14,236 | - |
| 199 | SGP | SpyGlass Pharma, Inc. | 668.67M | -0.10% | 23,515 | - |
| 200 | GYRE | Gyre Therapeutics, Inc. | 668.38M | 1.96% | 4,825 | 117.05M |
| 201 | IMMX | Immix Biopharma, Inc. | 665.63M | 6.25% | 684,955 | - |
| 202 | ACHV | Achieve Life Sciences, Inc. | 650.86M | 1.60% | 72,868 | - |
| 203 | MDXG | MiMedx Group, Inc. | 637.49M | -1.15% | 95,129 | 389.42M |
| 204 | SLBT | SL Science Holding Limited | 635.19M | - | 8,325 | 3.36M |
| 205 | SPRY | ARS Pharmaceuticals, Inc. | 628.59M | -1.71% | 503,993 | 98.99M |
| 206 | ALLO | Allogene Therapeutics, Inc. | 624.73M | 2.26% | 608,010 | 22.00K |
| 207 | CRMD | CorMedix Inc. | 619.77M | 1.54% | 66,243 | 400.05M |
| 208 | TECX | Tectonic Therapeutic, Inc. | 611.17M | 1.00% | 4,881 | - |
| 209 | AGMB | AgomAb Therapeutics NV | 598.86M | 1.50% | 20,168 | - |
| 210 | FDMT | 4D Molecular Therapeutics, Inc. | 595.43M | 2.71% | 55,770 | 88.24M |
| 211 | NVCT | Nuvectis Pharma, Inc. | 583.54M | 2.66% | 25,551 | - |
| 212 | ALT | Altimmune, Inc. | 556.20M | 1.78% | 176,409 | 36.00K |
| 213 | STTK | Shattuck Labs, Inc. | 552.10M | 5.57% | 104,611 | 1.00M |
| 214 | PRME | Prime Medicine, Inc. | 547.27M | -0.66% | 1,192,166 | 4.03M |
| 215 | EIKN | Eikon Therapeutics, Inc. | 535.16M | 2.44% | 20,735 | - |
| 216 | RGNX | REGENXBIO Inc. | 531.72M | -0.34% | 269,288 | 87.82M |
| 217 | CBIO | Crescent Biopharma, Inc. | 527.35M | 5.45% | 50,698 | 11.88M |
| 218 | ARVN | Arvinas, Inc. | 525.85M | 1.62% | 77,849 | 89.40M |
| 219 | ASMB | Assembly Biosciences, Inc. | 523.37M | 5.39% | 26,659 | 71.10M |
| 220 | RLMD | Relmada Therapeutics, Inc. | 522.35M | -0.40% | 114,633 | - |
| 221 | CTNM | Contineum Therapeutics, Inc. | 516.31M | 2.07% | 8,820 | - |
| 222 | ZURA | Zura Bio Limited | 512.04M | 2.47% | 35,789 | - |
| 223 | VSTM | Verastem, Inc. | 508.35M | 0.61% | 161,946 | 49.59M |
| 224 | SLN | Silence Therapeutics plc | 502.57M | 1.43% | 4,214 | 839.00K |
| 225 | DNA | Ginkgo Bioworks Holdings, Inc. | 502.35M | 1.85% | 69,667 | 151.40M |
| 226 | ANL | Adlai Nortye Ltd. | 485.60M | 1.34% | 15,078 | 5.00M |
| 227 | RZLT | Rezolute, Inc. | 484.73M | 4.27% | 90,902 | - |
| 228 | HELP | Cybin Inc. | 480.69M | 9.07% | 983,361 | - |
| 229 | PROK | ProKidney Corp. | 478.76M | 1.60% | 96,297 | 889.00K |
| 230 | VALN | Valneva SE | 460.86M | 2.38% | 1,083 | 180.25M |
| 231 | CABA | Cabaletta Bio, Inc. | 459.81M | 2.55% | 206,260 | - |
| 232 | PRTA | Prothena Corporation plc | 457.57M | 0.81% | 63,610 | 57.94M |
| 233 | ARTV | Artiva Biotherapeutics, Inc. | 454.30M | 2.19% | 69,255 | 251.00K |
| 234 | OCGN | Ocugen, Inc. | 453.62M | 0.75% | 1,068,088 | 4.47M |
| 235 | EDIT | Editas Medicine, Inc. | 445.81M | 0.87% | 118,768 | 38.69M |
| 236 | KYTX | Kyverna Therapeutics, Inc. | 443.81M | 0.83% | 224,497 | - |
| 237 | SGMT | Sagimet Biosciences Inc. | 440.91M | -0.28% | 66,786 | - |
| 238 | OVID | Ovid Therapeutics Inc. | 433.94M | 0.87% | 172,033 | 7.12M |
| 239 | PBYI | Puma Biotechnology, Inc. | 424.71M | 0.53% | 8,400 | 227.18M |
| 240 | EVMN | Evommune, Inc. | 424.30M | 2.17% | 19,105 | 10.00M |
| 241 | BNTC | Benitec Biopharma Inc. | 413.28M | 0.50% | 2,419 | - |
| 242 | PRLD | Prelude Therapeutics Incorporated | 411.59M | 2.22% | 13,373 | 16.72M |
| 243 | LRMR | Larimar Therapeutics, Inc. | 410.75M | 2.74% | 106,850 | - |
| 244 | EPRX | Eupraxia Pharmaceuticals Inc. | 410.29M | 1.68% | 11,836 | - |
| 245 | CCCC | C4 Therapeutics, Inc. | 407.99M | 3.07% | 255,218 | 34.86M |
| 246 | VTVT | vTv Therapeutics Inc. | 405.17M | 0.83% | 10,591 | 36.84M |
| 247 | IPSC | Century Therapeutics, Inc. | 398.58M | 0.91% | 64,765 | 109.16M |
| 248 | AUTL | Autolus Therapeutics plc | 389.90M | 4.64% | 309,795 | 92.62M |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 387.91M | 1.37% | 7,307 | 69.21M |
| 250 | IKT | Inhibikase Therapeutics, Inc. | 386.86M | 1.79% | 190,379 | 1.00 |
| 251 | UPB | Upstream Bio, Inc. | 384.21M | 1.15% | 15,812 | 3.32M |
| 252 | DMAC | DiaMedica Therapeutics Inc. | 382.57M | 1.28% | 6,285 | - |
| 253 | AVIR | Atea Pharmaceuticals, Inc. | 381.73M | -0.10% | 22,090 | - |
| 254 | STRO | Sutro Biopharma, Inc. | 379.46M | 1.37% | 21,728 | 99.61M |
| 255 | RCKT | Rocket Pharmaceuticals, Inc. | 373.44M | -0.29% | 114,060 | - |
| 256 | ZNTL | Zentalis Pharmaceuticals, Inc. | 366.61M | 2.79% | 175,710 | 26.87M |
| 257 | CMPX | Compass Therapeutics, Inc. | 366.48M | 0.74% | 204,013 | 850.00K |
| 258 | LXEO | Lexeo Therapeutics, Inc. | 360.41M | 0.88% | 19,411 | - |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 354.17M | 2.04% | 34,601 | 9.01M |
| 260 | ABEO | Abeona Therapeutics Inc. | 353.08M | -4.40% | 516,606 | 14.54M |
| 261 | FENC | Fennec Pharmaceuticals Inc. | 342.51M | -0.40% | 23,901 | 51.00M |
| 262 | PALI | Palisade Bio, Inc. | 334.14M | 0.79% | 106,742 | - |
| 263 | VCRE | Vicore Pharma Holding AB (publ) | 328.38M | 4.02% | 1,619 | 370.61K |
| 264 | FATE | Fate Therapeutics, Inc. | 327.53M | 0.54% | 101,928 | 6.32M |
| 265 | VNDA | Vanda Pharmaceuticals Inc. | 322.93M | 0.94% | 39,465 | 217.78M |
| 266 | LYEL | Lyell Immunopharma, Inc. | 316.35M | -0.08% | 4,317 | 31.00K |
| 267 | FHTX | Foghorn Therapeutics Inc. | 307.02M | 0.75% | 15,976 | 28.22M |
| 268 | ELDN | Eledon Pharmaceuticals, Inc. | 306.12M | 2.59% | 80,967 | - |
| 269 | NMRA | Neumora Therapeutics, Inc. | 305.72M | 1.23% | 40,192 | - |
| 270 | TTRX | Turn Therapeutics Inc. | 300.86M | 0.50% | 3,479 | - |
| 271 | OABI | OmniAb, Inc. | 300.09M | -0.48% | 30,064 | 28.94M |
| 272 | BCYC | Bicycle Therapeutics plc | 290.76M | 0.12% | 15,628 | 63.50M |
| 273 | IMRX | Immuneering Corporation | 286.29M | 3.15% | 120,137 | - |
| 274 | LCTX | Lineage Cell Therapeutics, Inc. | 280.46M | 2.27% | 71,277 | 14.78M |
| 275 | ALXO | ALX Oncology Holdings Inc. | 277.87M | 7.55% | 224,933 | - |
| 276 | MGNX | MacroGenics, Inc. | 277.77M | 1.16% | 48,546 | 157.08M |
| 277 | SABS | SAB Biotherapeutics, Inc. | 277.56M | 3.42% | 83,274 | 114.70K |
| 278 | SLGL | Sol-Gel Technologies Ltd. | 272.96M | 4.24% | 8,347 | 18.47M |
| 279 | NAGE | Niagen Bioscience, Inc. | 271.36M | 0.89% | 44,722 | 130.42M |
| 280 | PRQR | ProQR Therapeutics N.V. | 270.25M | 8.81% | 642,115 | 15.73M |
| 281 | INDP | Indaptus Therapeutics, Inc. | 268.38M | -3.66% | 6,338 | - |
| 282 | OTLK | Outlook Therapeutics, Inc. | 268.34M | 3.99% | 1,001,155 | 333.14K |
| 283 | IFRX | InflaRx N.V. | 268.07M | - | 60,449 | 33.82K |
| 284 | GALT | Galectin Therapeutics Inc. | 262.11M | -0.50% | 30,310 | - |
| 285 | SRZN | Surrozen, Inc. | 260.89M | 1.40% | 15,789 | 7.49M |
| 286 | IRD | Opus Genetics, Inc. | 248.52M | -1.31% | 95,892 | 11.98M |
| 287 | FULC | Fulcrum Therapeutics, Inc. | 245.54M | 1.80% | 220,185 | 80.00M |
| 288 | QTTB | Q32 Bio Inc. | 241.97M | -5.12% | 147,432 | 53.74M |
| 289 | ADAG | Adagene Inc. | 241.16M | 0.83% | 8,216 | 7.67M |
| 290 | RNAC | Cartesian Therapeutics, Inc. | 235.64M | -1.96% | 18,914 | 1.78M |
| 291 | CNXU | Conexeu Sciences Inc. | 234.67M | -1.24% | 21,900 | - |
| 292 | TARA | Protara Therapeutics, Inc. | 229.88M | 0.49% | 27,772 | - |
| 293 | TRDA | Entrada Therapeutics, Inc. | 229.53M | 0.47% | 16,994 | 5.74M |
| 294 | AVXL | Anavex Life Sciences Corp. | 228.44M | 1.86% | 123,590 | - |
| 295 | ACIU | AC Immune SA | 226.18M | 1.33% | 25,563 | 4.62M |
| 296 | CGEN | Compugen Ltd. | 225.11M | 1.71% | 13,957 | 72.66M |
| 297 | CHRS | Coherus Oncology, Inc. | 219.81M | 0.35% | 62,014 | 46.88M |
| 298 | OBIO | Orchestra BioMed Holdings, Inc. | 218.56M | -1.62% | 16,203 | 32.72M |
| 299 | NAUT | Nautilus Biotechnology, Inc. | 217.30M | 1.18% | 83,880 | - |
| 300 | AGEN | Agenus Inc. | 216.54M | 4.63% | 222,941 | 123.87M |
| 301 | KROS | Keros Therapeutics, Inc. | 209.69M | -0.14% | 9,320 | 33.18M |
| 302 | IVVD | Invivyd, Inc. | 206.67M | 2.36% | 271,941 | 55.87M |
| 303 | IMUX | Immunic, Inc. | 206.16M | 0.90% | 7,963 | - |
| 304 | NBP | NovaBridge Biosciences | 205.67M | -0.65% | 50,931 | - |
| 305 | GLSI | Greenwich LifeSciences, Inc. | 205.49M | -0.50% | 88,305 | - |
| 306 | RNA | Atrium Therapeutics, Inc. | 205.44M | 2.13% | 41,532 | 36.68M |
| 307 | CDXS | Codexis, Inc. | 205.43M | 2.26% | 22,180 | 78.09M |
| 308 | WHWK | Whitehawk Therapeutics, Inc. | 204.91M | 0.53% | 14,023 | 7.15M |
| 309 | NERV | Minerva Neurosciences, Inc. | 200.80M | -1.37% | 7,906 | - |
| 310 | DTIL | Precision BioSciences, Inc. | 193.00M | 1.63% | 27,708 | 45.07M |
| 311 | PLX | Protalix BioTherapeutics, Inc. | 192.57M | -0.83% | 31,771 | 76.38M |
| 312 | CLLS | Cellectis S.A. | 190.18M | 5.38% | 1,090 | 75.11M |
| 313 | NKTX | Nkarta, Inc. | 188.16M | 2.33% | 27,089 | - |
| 314 | NGEN | NervGen Pharma Corp. | 187.98M | 2.31% | 148,987 | - |
| 315 | HUMA | Humacyte, Inc. | 187.59M | 6.02% | 1,302,192 | 2.02M |
| 316 | VYGR | Voyager Therapeutics, Inc. | 187.31M | 1.64% | 116,152 | 36.49M |
| 317 | MDWD | MediWound Ltd. | 186.04M | -0.86% | 17,229 | 14.48M |
| 318 | ARMP | Armata Pharmaceuticals, Inc. | 184.47M | -0.69% | 29,377 | 5.20M |
| 319 | ACOG | Alpha Cognition Inc. | 183.77M | 1.20% | 3,991 | 10.83M |
| 320 | KPTI | Karyopharm Therapeutics Inc. | 182.66M | 7.90% | 158,351 | 151.12M |
| 321 | TNXP | Tonix Pharmaceuticals Holding Corp. | 181.57M | 3.73% | 117,664 | 17.56M |
| 322 | ANTX | AN2 Therapeutics, Inc. | 177.20M | 2.50% | 10,550 | - |
| 323 | TNYA | Tenaya Therapeutics, Inc. | 173.82M | -2.10% | 244,137 | 225.00K |
| 324 | MENS | Jyong Biotech Ltd. | 173.71M | 0.86% | 5,285 | - |
| 325 | KRRO | Korro Bio, Inc. | 172.64M | 4.09% | 20,320 | 3.84M |
| 326 | NRXP | NRx Pharmaceuticals, Inc. | 170.99M | -2.39% | 110,295 | 2.29M |
| 327 | ARCT | Arcturus Therapeutics Holdings Inc. | 170.82M | 0.67% | 55,286 | 54.71M |
| 328 | ORMP | Oramed Pharmaceuticals Inc. | 169.43M | 0.98% | 77,708 | 2.00M |
| 329 | CAMP | Camp4 Therapeutics Corporation | 167.77M | -2.68% | 10,094 | 3.93M |
| 330 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 166.94M | 1.35% | 7,139 | - |
| 331 | EQ | Equillium, Inc. | 165.00M | 5.65% | 67,107 | 4.39M |
| 332 | MIST | Milestone Pharmaceuticals Inc. | 164.62M | 2.54% | 152,790 | 1.78M |
| 333 | OKUR | OnKure Therapeutics, Inc. | 164.21M | -1.33% | 30,500 | - |
| 334 | CRBU | Caribou Biosciences, Inc. | 162.66M | 1.23% | 362,993 | 11.20M |
| 335 | ALEC | Alector, Inc. | 162.10M | 2.10% | 74,643 | 18.42M |
| 336 | ABOS | Acumen Pharmaceuticals, Inc. | 161.79M | 1.36% | 22,642 | - |
| 337 | IPHA | Innate Pharma S.A. | 160.79M | 3.47% | 1,252 | 10.57M |
| 338 | YDES | YD Bio Limited | 159.63M | - | 360 | 510.36K |
| 339 | CNTN | Canton Strategic Holdings, Inc. | 159.26M | 0.73% | 88,066 | - |
| 340 | KZIA | Kazia Therapeutics Limited | 157.81M | 1.92% | 21,527 | 1.27M |
| 341 | LENZ | LENZ Therapeutics, Inc. | 156.26M | 0.48% | 72,722 | 20.99M |
| 342 | PEPG | PepGen Inc. | 150.79M | -0.91% | 130,771 | - |
| 343 | UNCY | Unicycive Therapeutics, Inc. | 150.66M | 0.92% | 164,026 | - |
| 344 | MOLN | Molecular Partners AG | 146.77M | - | 5 | 856.30K |
| 345 | HURA | TuHURA Biosciences, Inc. | 145.51M | 2.01% | 13,153 | - |
| 346 | PYXS | Pyxis Oncology, Inc. | 144.45M | 1.33% | 29,472 | 13.86M |
| 347 | CBUS | Cibus, Inc. | 141.98M | 5.68% | 49,031 | 4.29M |
| 348 | CNTB | Connect Biopharma Holdings Limited | 137.83M | -0.50% | 17,560 | 233.00K |
| 349 | CUE | Cue Biopharma, Inc. | 133.53M | 2.71% | 5,755 | 32.73M |
| 350 | TLSA | Tiziana Life Sciences Ltd | 131.88M | 0.48% | 36,200 | - |
| 351 | PMN | ProMIS Neurosciences, Inc. | 130.03M | -3.81% | 11,288 | - |
| 352 | GNLX | Genelux Corporation | 128.34M | -1.37% | 8,537 | 8.00K |
| 353 | ENGN | enGene Therapeutics Inc. | 127.95M | 2.14% | 40,380 | - |
| 354 | GUTS | Fractyl Health, Inc. | 122.25M | -1.31% | 332,196 | 3.00K |
| 355 | SPRB | Spruce Biosciences, Inc. | 121.82M | -0.54% | 1,115 | 697.00K |
| 356 | VANI | Vivani Medical, Inc. | 121.59M | 4.44% | 37,335 | - |
| 357 | ANIX | Anixa Biosciences, Inc. | 119.76M | 1.73% | 72,713 | - |
| 358 | AARD | Aardvark Therapeutics, Inc. | 118.68M | -1.63% | 11,291 | - |
| 359 | FBIO | Fortress Biotech, Inc. | 117.60M | 6.31% | 84,393 | 66.16M |
| 360 | SEER | Seer, Inc. | 112.44M | 0.25% | 36,034 | 15.17M |
| 361 | PLYX | Polaryx Therapeutics, Inc. | 107.47M | 0.44% | 2,438 | - |
| 362 | BDTX | Black Diamond Therapeutics, Inc. | 105.72M | 1.93% | 56,291 | 70.00M |
| 363 | COYA | Coya Therapeutics, Inc. | 104.90M | 0.72% | 47,127 | 7.94M |
| 364 | ALDX | Aldeyra Therapeutics, Inc. | 103.15M | 0.59% | 58,110 | - |
| 365 | ONCY | Oncolytics Biotech Inc. | 101.69M | 0.24% | 129,178 | - |
| 366 | ICCC | ImmuCell Corporation | 100.87M | - | 1,398 | 29.93M |
| 367 | ENTX | Entera Bio Ltd. | 98.09M | - | 6,301 | 42.00K |
| 368 | VRCA | Verrica Pharmaceuticals Inc. | 97.40M | 3.28% | 849 | 37.16M |
| 369 | PTHS | Pelthos Therapeutics Inc. | 94.92M | 0.18% | 16,588 | 27.70M |
| 370 | BMEA | Biomea Fusion, Inc. | 93.63M | -1.15% | 99,319 | - |
| 371 | CGTX | Cognition Therapeutics, Inc. | 91.29M | 7.53% | 88,146 | - |
| 372 | HRTX | Heron Therapeutics, Inc. | 90.40M | -0.58% | 130,304 | 150.71M |
| 373 | KLRS | Kalaris Therapeutics, Inc. | 90.17M | -5.25% | 127,997 | - |
| 374 | INO | Inovio Pharmaceuticals, Inc. | 89.64M | -0.04% | 108,515 | 65.34K |
| 375 | RLYB | Rallybio Corporation | 87.58M | -1.08% | 1,955 | 858.00K |
| 376 | NRXS | NeurAxis, Inc. | 85.58M | 0.73% | 2,118 | 4.28M |
| 377 | NTHI | NeOnc Technologies Holdings, Inc. | 85.32M | 0.61% | 5,800 | 39.99K |
| 378 | CSBR | Champions Oncology, Inc. | 84.71M | - | 40 | 57.95M |
| 379 | ACET | Adicet Bio, Inc. | 83.90M | 1.27% | 13,306 | - |
| 380 | ATHE | Alterity Therapeutics Limited | 83.74M | - | 15 | 4.43M |
| 381 | SPRO | Spero Therapeutics, Inc. | 81.93M | -1.74% | 1,074,568 | 61.19M |
| 382 | PYPD | PolyPid Ltd. | 81.49M | -17.48% | 616,930 | - |
| 383 | RANI | Rani Therapeutics Holdings, Inc. | 80.45M | -5.38% | 179,699 | 3.17M |
| 384 | MAIA | MAIA Biotechnology, Inc. | 78.43M | 0.78% | 28,367 | - |
| 385 | RNTX | Rein Therapeutics Inc. | 77.38M | -1.46% | 150,466 | - |
| 386 | ENLV | Enlivex Ltd. | 75.21M | 0.86% | 6,743 | - |
| 387 | ALPS | Alps Group Inc | 74.88M | -4.74% | 852 | 3.74M |
| 388 | ACRV | Acrivon Therapeutics, Inc. | 74.69M | 0.29% | 2,797 | - |
| 389 | ATRA | Atara Biotherapeutics, Inc. | 73.70M | -1.33% | 3,788 | 23.14M |
| 390 | ANVS | Annovis Bio, Inc. | 73.60M | 2.37% | 42,063 | - |
| 391 | OKYO | OKYO Pharma Limited | 73.47M | 2.19% | 42,164 | - |
| 392 | GANX | Gain Therapeutics, Inc. | 72.94M | 4.91% | 139,288 | - |
| 393 | GOSS | Gossamer Bio, Inc. | 72.84M | 5.67% | 3,583,340 | 55.54M |
| 394 | HYFT | MindWalk Holdings Corp. | 71.52M | 0.70% | 24,328 | 20.70M |
| 395 | LONA | LeonaBio, Inc. | 71.11M | - | 335 | - |
| 396 | TELO | Telomir Pharmaceuticals, Inc. | 70.49M | 11.51% | 52,877 | - |
| 397 | PMVP | PMV Pharmaceuticals, Inc. | 69.33M | 1.56% | 13,961 | - |
| 398 | IMA | ImageneBio, Inc. | 68.80M | 6.46% | 205 | 800.00K |
| 399 | OSTX | OS Therapies Incorporated | 68.14M | 1.32% | 34,601 | - |
| 400 | IBIO | iBio, Inc. | 68.06M | - | 31,069 | 300.00K |
| 401 | XBIT | XBiotech Inc. | 67.38M | -1.78% | 26,813 | - |
| 402 | PLRX | Pliant Therapeutics, Inc. | 66.87M | 0.93% | 70,897 | - |
| 403 | MNOV | MediciNova, Inc. | 65.46M | -0.75% | 1,784 | 596.64K |
| 404 | CING | Cingulate Inc. | 63.44M | 3.29% | 21,610 | - |
| 405 | TCRX | TScan Therapeutics, Inc. | 60.80M | 0.62% | 27,644 | 9.14M |
| 406 | ELTX | Elicio Therapeutics, Inc. | 58.84M | 1.48% | 43,597 | - |
| 407 | CRDF | Cardiff Oncology, Inc. | 58.05M | 1.24% | 178,490 | 525.00K |
| 408 | CNTX | Context Therapeutics Inc. | 56.94M | 0.60% | 214,474 | - |
| 409 | EDSA | Edesa Biotech, Inc. | 56.91M | 9.97% | 15,997 | - |
| 410 | BOLD | Boundless Bio, Inc. | 55.71M | 1.64% | 11,473 | - |
| 411 | VRXA | Veraxa Biotech AG | 55.48M | 3.77% | 34,869 | - |
| 412 | INKT | MiNK Therapeutics, Inc. | 53.85M | 0.37% | 3,103 | - |
| 413 | INMB | INmune Bio Inc. | 51.84M | -2.01% | 85,425 | 50.00K |
| 414 | BYSI | BeyondSpring Inc. | 51.40M | 0.81% | 4,211 | 1.88M |
| 415 | DYAI | Dyadic International, Inc. | 51.38M | 16.53% | 67,245 | 3.81M |
| 416 | XLO | Xilio Therapeutics, Inc. | 51.12M | -0.29% | 5,729 | 53.48M |
| 417 | IMMP | Immutep Limited | 50.55M | -3.09% | 26,445 | 5.28M |
| 418 | MCRB | Seres Therapeutics, Inc. | 49.87M | 0.78% | 6,018 | 1.15M |
| 419 | RADX | Radiopharm Theranostics Limited | 49.62M | - | 6,881 | 10.86M |
| 420 | EXOZ | eXoZymes, Inc. | 49.43M | 4.11% | 926 | -700.00 |
| 421 | FLNA | Filana Therapeutics, Inc. | 49.27M | - | 68,695 | - |
| 422 | MREO | Mereo BioPharma Group plc | 48.81M | 0.20% | 38,669 | 500.00K |
| 423 | TIL | Instil Bio, Inc. | 48.76M | -0.83% | 227 | - |
| 424 | IBO | Impact BioMedical Inc. | 48.52M | 1.12% | 11,317 | 39.00K |
| 425 | ELOX | Eloxx Pharmaceuticals, Inc. | 47.63M | 1.29% | 5,011 | - |
| 426 | ATYR | aTyr Pharma, Inc. | 47.57M | -0.25% | 73,073 | 190.00K |
| 427 | DWTX | Dogwood Therapeutics, Inc. | 46.41M | - | 998 | - |
| 428 | MGX | Metagenomi Therapeutics, Inc. | 45.55M | -0.82% | 85,705 | 22.33M |
| 429 | HYPD | Hyperion DeFi, Inc. | 42.97M | 4.23% | 28,515 | 1.04M |
| 430 | PDSB | PDS Biotechnology Corporation | 42.70M | 6.66% | 58,098 | - |
| 431 | APLM | Apollomics, Inc. | 41.42M | - | 114 | 8.84M |
| 432 | GRCE | Grace Therapeutics, Inc. | 40.20M | 1.65% | 3,470 | - |
| 433 | NNVC | NanoViricides, Inc. | 39.87M | - | 27,220 | - |
| 434 | RNXT | RenovoRx, Inc. | 39.47M | 1.32% | 5,286 | 1.49M |
| 435 | CRVO | CervoMed Inc. | 38.48M | 1.97% | 65,713 | 2.09M |
| 436 | VERU | Veru Inc. | 37.48M | 1.52% | 22,939 | 16.89M |
| 437 | NTRB | Nutriband Inc. | 37.08M | -0.97% | 470 | 1.80M |
| 438 | LTRN | Lantern Pharma Inc. | 36.75M | -2.37% | 12,057 | - |
| 439 | LITS | Lite Strategy, Inc. | 36.74M | 4.84% | 19,548 | - |
| 440 | GNTA | Genenta Science S.p.A. | 35.86M | -3.80% | 13,348 | - |
| 441 | ACTU | Actuate Therapeutics, Inc. | 34.57M | 3.21% | 6,320 | - |
| 442 | ESLA | Estrella Immunopharma, Inc. | 34.00M | -4.23% | 8,543 | - |
| 443 | ALGS | Aligos Therapeutics, Inc. | 33.48M | 2.46% | 26,229 | 4.71M |
| 444 | SER | Serina Therapeutics, Inc. | 31.94M | -2.29% | 698 | 130.00K |
| 445 | BCTX | BriaCell Therapeutics Corp. | 31.50M | 1.10% | 8,651 | - |
| 446 | ABVC | ABVC BioPharma, Inc. | 30.32M | - | 6,826 | 797.92K |
| 447 | VYNE | VYNE Therapeutics Inc. | 28.83M | 6.99% | 2,909,742 | 454.00K |
| 448 | KYNB | Kyntra Bio, Inc. | 28.65M | 0.54% | 1,092 | 7.44M |
| 449 | ATNM | Actinium Pharmaceuticals, Inc. | 27.92M | 0.79% | 17,729 | 90.00K |
| 450 | TVRD | Tvardi Therapeutics, Inc. | 27.67M | 0.68% | 89,009 | - |
| 451 | PSTV | Plus Therapeutics, Inc. | 27.60M | 4.70% | 20,402 | 5.18M |
| 452 | IGC | IGC Pharma, Inc. | 26.92M | 0.41% | 34,738 | 1.11M |
| 453 | BRNS | Barinthus Biotherapeutics plc | 25.08M | -0.48% | 2,339 | 14.97M |
| 454 | NRSN | NeuroSense Therapeutics Ltd. | 24.74M | 1.51% | 8,555 | - |
| 455 | EVAX | Evaxion A/S | 24.60M | 0.34% | 4,647 | 7.53M |
| 456 | PLRZ | Polyrizon Ltd. | 24.54M | -1.13% | 1,044 | - |
| 457 | GRDX | GridAI Technologies Corp. | 23.69M | 11.25% | 31,553 | - |
| 458 | JSPR | Jasper Therapeutics, Inc. | 23.49M | 3.07% | 423,692 | - |
| 459 | CELU | Celularity Inc. | 22.87M | 1.28% | 1,608 | 26.55M |
| 460 | SKYE | Skye Bioscience, Inc. | 22.78M | -0.84% | 16,013 | - |
| 461 | ATOS | Atossa Therapeutics, Inc. | 22.22M | 3.61% | 21,766 | - |
| 462 | CVM | CEL-SCI Corporation | 22.11M | -0.39% | 53,133 | - |
| 463 | MRKR | Marker Therapeutics, Inc. | 21.68M | 1.56% | 563 | 3.55M |
| 464 | LSTA | Lisata Therapeutics, Inc. | 21.40M | -33.33% | 63,906 | 170.00K |
| 465 | PLUR | Pluri Inc. | 20.72M | 5.49% | 2,003 | 1.08M |
| 466 | NCEL | NewcelX Ltd. | 20.46M | -4.28% | 1,474 | - |
| 467 | CLRB | Cellectar Biosciences, Inc. | 20.14M | - | 1,666 | - |
| 468 | LGVN | Longeveron Inc. | 19.59M | 2.94% | 15,342 | 1.22M |
| 469 | QNTM | Quantum BioPharma Ltd. | 19.39M | -1.64% | 16,969 | - |
| 470 | NXTC | NextCure, Inc. | 19.25M | -1.30% | 130,446 | - |
| 471 | DARE | Daré Bioscience, Inc. | 19.17M | -4.48% | 168,885 | 1.16M |
| 472 | ALLR | Allarity Therapeutics, Inc. | 18.93M | 1.71% | 1,119 | 345.00K |
| 473 | QNCX | Quince Therapeutics, Inc. | 18.33M | -0.40% | 871 | - |
| 474 | NEUP | Neuphoria Therapeutics Inc. | 18.21M | 2.12% | 1,417 | -13.27K |
| 475 | LPCN | Lipocine Inc. | 17.81M | 0.47% | 3,437 | 2.00M |
| 476 | HOWL | Werewolf Therapeutics, Inc. | 17.74M | -0.82% | 81,156 | 1.14M |
| 477 | AKTX | Akari Therapeutics, Plc | 17.63M | -5.53% | 34,426 | - |
| 478 | TVGN | Tevogen Bio Holdings Inc. | 16.24M | -1.03% | 646 | - |
| 479 | PTN | Palatin Technologies, Inc. | 16.03M | - | 268 | 12.88M |
| 480 | OSRH | OSR Health, Inc. | 15.45M | -4.90% | 266,548 | 2.63M |
| 481 | PASG | Passage Bio, Inc. | 15.37M | -0.42% | 616 | - |
| 482 | CYCN | Cyclerion Therapeutics, Inc. | 15.27M | -1.37% | 1,966 | 1.99M |
| 483 | ICU | SeaStar Medical Holding Corporation | 15.24M | -1.53% | 20,323 | 1.44M |
| 484 | HIND | Vyome Holdings, Inc. | 15.02M | -2.28% | 1,385 | 152.72K |
| 485 | SNTI | Senti Biosciences Holdings, Inc. | 14.84M | 9.87% | 112,713 | 38.00K |
| 486 | KTTA | Pasithea Therapeutics Corp. | 14.71M | -6.97% | 120,371 | - |
| 487 | LEXX | Lexaria Bioscience Corp. | 14.58M | -1.98% | 1,331 | 194.00K |
| 488 | MLEC | Moolec Science SA | 14.35M | 4.55% | 4,392 | 7.83M |
| 489 | TPST | Tempest Therapeutics, Inc. | 14.23M | 0.88% | 289,209 | - |
| 490 | KALA | KALA BIO, Inc. | 14.13M | 1.35% | 24,583 | - |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 13.79M | 4.54% | 323,477 | 5.61M |
| 492 | PHIO | Phio Pharmaceuticals Corp. | 13.13M | 4.63% | 121,260 | - |
| 493 | COCP | Cocrystal Pharma, Inc. | 13.06M | 1.84% | 4,031 | 225.00K |
| 494 | LNAI | Lunai Bioworks Inc. | 13.01M | 8.71% | 8,960 | 20.94K |
| 495 | BLRX | BioLineRx Ltd. | 12.88M | 2.12% | 3,683 | 1.40M |
| 496 | GTBP | GT Biopharma, Inc. | 12.61M | 2.55% | 141,443 | - |
| 497 | INTS | Intensity Therapeutics, Inc. | 12.43M | -2.13% | 11,782 | - |
| 498 | PBM | Psyence Biomedical Ltd. | 12.28M | 1.90% | 6,528 | - |
| 499 | XCUR | Exicure, Inc. | 12.27M | 1.85% | 33,366 | 500.00K |
| 500 | INAB | IN8bio, Inc. | 12.16M | -1.98% | 9,852 | - |